Siemens Healthineers AG (ETR:SHL)
46.11
-0.07 (-0.15%)
Jul 16, 2025, 5:35 PM CET
Revenue by Product
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
Imaging | 12.27B | Log In | Log In | Log In | Log In | Upgrade |
Imaging Growth | 7.36% | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics | 4.42B | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Growth | -0.40% | Log In | Log In | Log In | Log In | Upgrade |
Advanced Therapies | 2.08B | Log In | Log In | Log In | Log In | Upgrade |
Advanced Therapies Growth | 3.81% | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from | -262.00M | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Growth | 18.82% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Varian | 3.87B | Log In | Log In | Log In | Log In | Upgrade |
Varian Growth | 10.39% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Revenue by Geography
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
EMEA | 7.44B | Log In | Log In | Log In | Log In | Upgrade |
EMEA Growth | 2.47% | Log In | Log In | Log In | Log In | Upgrade |
Americas | 9.43B | Log In | Log In | Log In | Log In | Upgrade |
Americas Growth | 12.30% | Log In | Log In | Log In | Log In | Upgrade |
Asia and Australia Revenue (Pre-FY2023 Reporting) | - | Log In | Log In | Log In | Log In | Upgrade |
Asia and Australia Revenue (Pre-FY2023 Reporting) Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Japan Revenue (Post-FY2022 Reporting) | 2.94B | Log In | Log In | Log In | Log In | Upgrade |
Asia Pacific Japan Revenue (Post-FY2022 Reporting) Growth | 4.72% | Log In | Log In | Log In | Log In | Upgrade |
China | 2.55B | Log In | Log In | Log In | Log In | Upgrade |
China Growth | -5.56% | Log In | Log In | Log In | Log In | Upgrade |
Other
Fiscal year is October - September.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2015 - 2019 |
---|---|---|---|---|---|---|
Period Ending | Sep '24 Sep 30, 2024 | Sep '23 Sep 30, 2023 | Sep '22 Sep 30, 2022 | Sep '21 Sep 30, 2021 | Sep '20 Sep 30, 2020 | 2015 - 2019 |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Imaging Income Before Taxes | 2.58B | Log In | Log In | Log In | Log In | Upgrade |
Imaging Income Before Taxes Growth | 23.08% | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Income Before Taxes | 235.00M | Log In | Log In | Log In | Log In | Upgrade |
Diagnostics Income Before Taxes Growth | 57.78% | Log In | Log In | Log In | Log In | Upgrade |
Advanced Therapies Income Before Taxes | 338.00M | Log In | Log In | Log In | Log In | Upgrade |
Advanced Therapies Income Before Taxes Growth | 20.00% | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Income Before Taxes | -1.27B | Log In | Log In | Log In | Log In | Upgrade |
Eliminations from Income Before Taxes Growth | -5.93% | Log In | Log In | Log In | Log In | Upgrade |
Other | - | Log In | Log In | Log In | Log In | Upgrade |
Other Growth | - | Log In | Log In | Log In | Log In | Upgrade |
Varian Income Before Taxes | 639.00M | Log In | Log In | Log In | Log In | Upgrade |
Varian Income Before Taxes Growth | -7.38% | Log In | Log In | Log In | Log In | Upgrade |
Equipment Book-to-Bill Ratio | 1.11 | Log In | Log In | Log In | Log In | Upgrade |